We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Advanced CT Test Simulates Blood Flow to Assess Risk in Patients with Angina

By MedImaging International staff writers
Posted on 13 Sep 2023
Print article
Image: CT-FFR provides blood-flow estimate similar to invasive heart catheterization (Photo courtesy of 123RF)
Image: CT-FFR provides blood-flow estimate similar to invasive heart catheterization (Photo courtesy of 123RF)

Coronary artery calcium is considered as a surrogate marker for total coronary plaque, a fatty buildup in the arteries that can result in a heart attack in the future. A calcium score above 400 is a warning sign of high plaque levels. Non-contrast enhanced cardiac CT is typically performed prior to CT angiography to determine the amount of coronary artery calcium. However, high calcium content can interfere with CT images, making them tough to evaluate. While CT angiography helps identify coronary artery disease, it does not reveal how this condition impacts blood flow. Disrupted blood flow can create abnormal pressure, making these plaques more likely to break open. Now, an advanced CT test can identify individuals with stable angina who are at a reduced risk for negative outcomes over three years, even if their calcium scores are high.

In a prospective study, researchers from the University Hospital of Southern Denmark (Esbjerg, Denmark) looked at the three-year clinical results of patients who went through CT angiography and another specialized scan known as CT angiography-derived fractional flow reserve (CT-FFR). This advanced test combines CT images, AI algorithms, and fluid dynamics calculations to mimic the blood flow in the coronary arteries. The study involved patients newly diagnosed with stable coronary artery disease, who were part of the ADVANCE clinical trial conducted between December 2015 and October 2017 across three locations in Denmark. To be part of this study, patients needed to have at least one coronary artery narrowed by more than 30% and must not have had a history of irregular heartbeats or previous procedures to improve heart blood flow.

Out of 900 participants, 523 had normal CT-FFR results (average age 64, 318 males) and 377 showed abnormal CT-FFR findings (average age 65, 264 males). The three-year adverse outcome rate, which includes death from any cause and non-fatal heart attacks, was just 2.1% (11 out of 523) in the normal CT-FFR group. On the other hand, this rate was 6.6% (25 out of 377) in the abnormal CT-FFR group. Interestingly, those with a high calcium score but normal CT-FFR results had a 2.2% (4 out of 182) adverse outcome rate over three years. The rate soared to 9% (19 out of 212) for those with both high calcium scores and abnormal CT-FFR results. According to the team, while there are various methods to study the effects of coronary artery disease on blood flow, CT-FFR stands out for its high diagnostic accuracy. It aligns well with fractional flow reserve, a more invasive measurement method. The researchers believe that CT-FFR could help doctors categorize patients by risk level and focus on improving the outlook for those at higher risk.

“Our study provides evidence for the prognostic potential of CT-FFR in patients with high coronary artery calcium scores,” said lead researcher Kristian T. Madsen, M.D. “Regardless of the patient’s baseline risk and extent of coronary artery disease measured by coronary artery calcium, if CT-FFR results are normal, the prognosis is good.”

“In my opinion, CT-FFR is the best option because it provides a blood-flow estimate similar to what you would obtain if you performed invasive heart catheterization. You get a reliable and quick answer without performing additional tests or putting the patient through an invasive procedure,” added Madsen. “CT-FFR provides diagnostic and prognostic information beyond what can be obtained from CT angiography alone across a wide range of coronary artery calcium levels. It’s a tool that offers a lot of exciting prospects for the future.”

Related Links:
University Hospital of Southern Denmark 

Gold Member
Solid State Kv/Dose Multi-Sensor
Mammography System
Oncology Information System
Ultrasound Needle Guide
Ultra-Pro II

Print article



view channel
Image: The study supports annual screening beginning at age 40 as the best way to diagnose cancer early (Photo courtesy of 123RF)

Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%

Breast cancer remains a leading cause of cancer-related deaths among women in the United States. Although studies have shown that regular mammography screenings can cut breast cancer fatalities by 40%,... Read more


view channel
Image: Researchers have created a new MRI brain extraction tool for neonates (Photo courtesy of 123RF)

Deep Learning Algorithm Performs Automatic Segmentation of Neonatal Brains from MR Images

Magnetic Resonance Imaging (MRI) is a vital tool in medical diagnostics, particularly because of its high-resolution images and superior soft tissue contrast, which make it crucial for brain evaluations.... Read more


view channel
Mindray`s comprehensive range of ultrasound machines include the Resona I9 (photo courtesy of Mindray)

Non-Invasive Ultrasound Technique Helps Identify Life-Changing Complications after Neck Surgery

Nasopharyngoscopy is an intrusive diagnostic medical procedure that involves the examination of the internal structures of the nose and throat (nasopharynx) using an endoscope inserted through the patient’s nose.... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.